Balchem to Showcase Functional Beverage and High-Protein Snack Prototypes at IFT FIRST 2026
Balchem will be exhibiting at IFT FIRST 2026, showcasing functional beverage and high-protein snack prototypes to address consumer demands for healthier, convenient, and sensory-appealing options. The company will introduce technologies like Milk Protein Z-Crisps for snacks, MeatShure for meat sticks, and INjoy and VitalBlend for beverages, aiming to streamline formulation and production efficiency. Balchem experts will also host technical sessions on better-for-you indulgence and simplifying beverage innovation.
Balchem highlights on-trend better-for-you concepts and smart formulation insights at IFT FIRST 2026
Balchem will feature better-for-you food and beverage concepts and formulation insights at IFT FIRST 2026, showcasing new functional prototypes like Milk Protein Z-Crisps and advanced microencapsulated ingredients. The company will also host two presentations on formulating indulgent high-protein, high-fiber applications and streamlining beverage innovation. Balchem aims to address consumer demand for convenient, wellness-supporting options that do not compromise on taste or texture.
ETFs Investing in Balchem Corp Stocks
This article provides a comprehensive list of Exchange Traded Funds (ETFs) that hold shares of Balchem Corp (BL9B). The ETFs are sorted by market value of their Balchem holdings and include details such as issuer, management style, expense ratio, assets under management, and past performance. This resource aims to help investors identify diverse options for gaining exposure to Balchem Corp stocks with potentially lower risk.
How Balchem’s Broad Russell Value Index Additions Will Impact Balchem (BCPC) Investors
Balchem Corporation (BCPC) has been added to multiple Russell value and small-cap indexes, including the Russell 2000 Value-Defensive Index. This inclusion is expected to increase Balchem's visibility among institutional investors and passive funds, potentially broadening its shareholder base and sharpening the debate around its valuation. The article also touches on Balchem’s investment narrative focusing on specialty nutrition and its projected financial growth.
How Balchem’s Broad Russell Value Index Additions Will Impact Balchem (BCPC) Investors
Balchem Corporation (NasdaqGS: BCPC) has been added to several Russell value and small-cap indexes, including the Russell 2000 Value-Defensive Index. This broad index inclusion is expected to increase Balchem's visibility among institutional investors and passive funds, potentially influencing its market perception and investment narrative. While the index additions are positive for visibility, investors are advised to focus on Balchem's specialty nutrition focus, operational efficiency, and innovation risks, alongside its participation in recent investor conferences.
Balchem Corporation(NasdaqGS: BCPC) added to Russell 2000 Value Benchmark
Balchem Corporation (NasdaqGS: BCPC) has been added to the Russell 2000 Value Benchmark. This news highlights the company's inclusion in a key market index, typically signaling recognition within the small-cap value sector. The article also provides recent updates on Balchem, including its Q1 2026 earnings and previous equity buyback plan tranches.
Balchem Corporation(NasdaqGS:BCPC) added to Russell Small Cap Comp Value Benchmark
Balchem Corporation (BCPC) has been added to the Russell Small Cap Comp Value Benchmark, as announced on June 28, 2026. This inclusion is one of several recent additions to various Russell benchmarks, including the Russell 2000 Value and Russell 3000E Value Benchmarks. The article also provides a company profile, financial data overviews, and analyst consensus ratings for Balchem Corporation.
Balchem Corporation(NasdaqGS: BCPC) added to Russell 2000 Value-Defensive Index
Balchem Corporation (NasdaqGS: BCPC) has been added to the Russell 2000 Value-Defensive Index. This announcement follows recent news of its inclusion in the Russell 2000 Value Benchmark CI and Russell 3000E Value Benchmark CI. Balchem specializes in developing and manufacturing performance ingredients for various markets, including human nutrition, animal health, and specialty products.
Price to earnings forward of Balchem Corporation – NASDAQ:BCPC
The article presents the "Price to earnings forward" data for Balchem Corporation (NASDAQ: BCPC). It displays a table with period, value, change, and change % columns. The content is primarily a data table with associated financial and market information, likely from a trading platform.
Enterprise value to EBITDA forward of Balchem Corp – BMV:BCPC
This article provides financial information for Balchem Corp (BMV:BCPC) on TradingView, specifically focusing on its Enterprise Value to EBITDA (forward) metric. It shows the period, value, and change for this financial indicator, noting that the market was closed with no trades at the time of publication.
Price to sales forward of Balchem Corp – BMV:BCPC
The article focuses on the "Price to sales forward" metric for Balchem Corp (BMV:BCPC). It lists the company's stock exchange and offers various financial and community features on the TradingView platform. The content is primarily a data point display with navigation for different sections of the platform.
Enterprise value to revenue forward of Balchem Corp – BMV:BCPC
This article provides financial data for Balchem Corp (BMV:BCPC), specifically focusing on its enterprise value to forward revenue. It presents this information within the context of the Mexican Stock Exchange, indicating it as a Consumer Non-Durables stock in the Food: Specialty/Candy sector. The content appears to be a snapshot from a financial data platform like TradingView rather than an in-depth analysis.
Enterprise value to EBIT forward of Balchem Corp – BMV:BCPC
This article presents a financial metric, the enterprise value to EBIT forward, for Balchem Corp (BMV:BCPC) on the Mexican Stock Exchange. The content appears to be a snapshot from a financial trading platform, indicating the market status and offering further financial data, news, and community insights about the company. No specific values for the metric are provided in the visible text.
Balchem Corp Actuals & Estimates (HAM:BL9B)
This article provides financial actuals and estimates for Balchem Corp (HAM:BL9B), including income statement, balance sheet, and cash flow data, alongside analyst price targets. It details the company's past earnings, revenue, net income, dividend information, and upcoming earnings report dates. The article also addresses common questions regarding its stock ticker, forecast, historical prices, and how to purchase shares.
Balchem Corporation to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026
Balchem Corporation announced it will participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026. Key executives, including Chairman and CEO Ted Harris, CFO Martin Bengtsson, and Senior Director of Investor Relations Allison Baurichter, will represent the company. Balchem is a global specialty ingredient manufacturer for health and nutrition markets, with segments in Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Balchem Corp Actuals & Estimates (NASDAQ:BCPC)
This article provides an overview of Balchem Corporation (NASDAQ: BCPC) stock performance, financial actuals and estimates, and analyst forecasts. It covers key metrics such as current stock price, market capitalization, earnings, revenue, dividends, and volatility, along with future projections and historical highs and lows.
Balchem Corporation to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026
Balchem Corporation announced its participation in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026. Key executives, including Chairman and CEO Ted Harris, CFO Martin Bengtsson, and Senior Director of Investor Relations Allison Baurichter, will represent the company. Balchem specializes in developing and manufacturing ingredient solutions for health and nutrition across human, animal, and specialty product markets.
Balchem Corporation to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026
Balchem Corporation announced its participation in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026. Key executives, including Chairman and CEO Ted Harris, CFO Martin Bengtsson, and Senior Director Investor Relations Allison Baurichter, will represent the company. Balchem is a global specialty ingredient manufacturer focusing on health and nutrition for various markets.
Balchem Corporation to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026
Balchem Corporation announced its participation in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026. Key executives, including Chairman and CEO Ted Harris, CFO Martin Bengtsson, and Senior Director Investor Relations Allison Baurichter, will attend. Balchem is a global specialty ingredient manufacturer known for its contributions to health and nutrition markets across Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products segments.
Balchem sends CEO, CFO to CJS Securities conference July 9
Balchem Corporation (NASDAQ:BCPC) announced its participation in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026. The company will be represented by CEO Ted Harris, CFO Martin Bengtsson, and Senior Director of Investor Relations Allison Baurichter. This engagement is part of Balchem's ongoing investor outreach efforts.
Balchem : to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026
Balchem Corporation announced it will participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026. Key executives, including Chairman and CEO Ted Harris, CFO Martin Bengtsson, and Senior Director of Investor Relations Allison Baurichter, will represent the company. The announcement was originally published on June 26, 2026, at 07:31 am EDT.
Balchem Corporation to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026
Balchem Corporation (NASDAQ: BCPC) announced its participation in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026. Ted Harris, Martin Bengtsson, and Allison Baurichter will represent the company. Balchem is a global specialty ingredient manufacturer for health and nutrition markets, with segments including Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Balchem Corp Actuals & Estimates (LSX:905650)
This article provides an overview of Balchem Corp (LSX:905650) stock performance, financial data, and analyst forecasts. It includes details on the current stock price, historical highs and lows, market capitalization, upcoming earnings reports, and dividend information. The content also addresses frequently asked questions regarding the company's financials for potential investors.
905650 Forecast — Price Target — Prediction for 2027
This article provides a forecast and price target for Balchem Corp (905650) stock, based on analyst opinions. It details the current stock price, historical performance, future earnings and revenue expectations, dividend information, and market capitalization. The article also includes answers to frequently asked questions about the company's stock.
Balchem (BCPC) Could Be 11% Undervalued As Growth Expectations Build
Balchem (BCPC) stock has gained attention, trading at $169.23 after recent positive price moves. While analysts suggest it could be 11.4% undervalued with a fair value of $191 based on cash flow projections and future growth expectations, its current P/E ratio of 34.4x is considerably higher than the industry average, posing a valuation risk. Investors are advised to examine underlying data and consider both the upside potential and valuation concerns.
Balchem Corp (BCPC) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Balchem Corp (BCPC), focusing on its stock price momentum, support and resistance levels, and key technical indicators. As of June 26, 2026, BCPC's price momentum score is 9.38, suggesting suitability for range-bound swing trading between resistance at $179.24 and support at $158.06. The analysis, based on moving averages and other technical indicators, currently signals a "Buy" for the stock.
Balchem signals double-digit growth potential with new $36M microencapsulation facility and strong Q2 2025 results
Balchem Corporation is investing $36 million in a new microencapsulation facility in Cambridge, Maryland, expected to be operational in early 2026. This expansion aims to support double-digit growth in its Human Nutrition & Health segment. The company also reported robust Q2 2025 results, with sales up 9% to $265 million and net earnings increasing by 12% to $38 million, reaffirming its strong financial health and growth prospects.
Balchem Corp (BCPC) Financial Health: Profitability & Balance Sheet Analysis
Balchem Corp (BCPC) has a robust financial score of 8.94, ranking 8th in the Chemicals industry. The company reported a year-over-year revenue increase of 8.06% and a net profit increase of 8.72% in its latest quarter, reaching $270.71M in revenue. Their financial health is strong due to high operating efficiency.
Balchem Corp (BCPC) Valuation: PE, PB & Fair Value Analysis
Balchem Corp (BCPC) currently has a valuation score of 6.21, placing it 65th out of 68 in the Chemicals industry. Its P/E ratio stands at 33.66, which is lower than its recent high but above its recent low. The article notes that P/B, P/S, and P/CF data have not yet been disclosed by the company.
Balchem shareholders elect directors and approve auditor at annual meeting By Investing.com
Balchem Corporation shareholders elected two Class 3 directors, David Fischer and Daniel Knutson, to the board to serve until the 2029 Annual Meeting. They also ratified RSM US LLP as the independent registered public accounting firm for fiscal year 2026 and provided advisory approval for executive compensation. These decisions follow Balchem's strong first-quarter 2026 financial results, which exceeded market expectations for adjusted EPS and revenue.
Form 8K Balchem Corporation For: 22 June By Investing.com
This article announces that Balchem Corporation filed a Form 8K on June 22. It provides a brief mention of the filing and lists various financial market data and popular articles from Investing.com. The information is presented without additional commentary on the 8K filing's content.
Form 8K Balchem Corporation For: 22 June By Investing.com
This article from Investing.com announces the filing of a Form 8K by Balchem Corporation on June 22nd. The content explicitly states the date and time of publication. The article itself is very brief and consists solely of this announcement and various financial market data and navigation.
Balchem (BCPC) investors reelect directors, approve auditor and executive pay
Balchem Corporation (BCPC) shareholders reelected two Class 3 directors, David Fischer and Daniel Knutson, to serve until the 2029 annual meeting. They also ratified RSM US LLP as the independent registered public accounting firm for fiscal year 2026 and gave advisory approval to the compensation of the company's named executive officers. These decisions were made during the Annual Meeting of Shareholders held on June 18, 2026.
Balchem Corp (BCPC) Institutional Confidence
Balchem Corp (BCPC) has an institutional shareholding score of 7.00, placing it 28th out of 68 in the Chemicals industry. Institutional investors hold 88.34% of its shares, a 4.74% decrease quarter-over-quarter. ETHSX is the largest institutional shareholder, holding 701.96K shares, which represents 2.07% of shares outstanding after a 734.00% increase in their holdings.
Balchem Corp (BCPC) Earnings Forecast: Future EPS & Revenue Growth Estimates
Balchem Corp (BCPC) has an earnings forecast score of 7.33, placing it 34th out of 68 in the Chemicals industry. Analysts have an average price target of $191.00 for BCPC, with a consensus "Buy" rating based on 3 analysts. The company's expected revenue for the next quarter is $268.50 million, and the expected EPS is $1.40.
Balchem highlights on-trend better-for-you concepts and smart formulation insights at IFT FIRST 2026
Balchem will be showcasing better-for-you food and beverage concepts and sharing formulation insights at IFT FIRST 2026. The company plans to present functional beverages and high-protein snack prototypes, including new Milk Protein Z-Crisps®, and will host two presentations on formulating for better-for-you indulgence and simplifying beverage innovation. These efforts aim to address consumer demand for convenient, wellness-supporting products that do not compromise on taste or texture.
Balchem Corp (BCPC) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Balchem Corp (BCPC), highlighting its major institutional shareholders and the proportion of shares they hold. It also provides a breakdown of shareholder types and historical institutional shareholding data from Q4 2023 to Q1 2026, alongside related ETF holdings.
Balchem Corp (BCPC) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article details the historical dividend payouts for Balchem Corp (BCPC), showing a consistent increase in cash dividends from 2020 through projections for 2025. It lists the dividend amount, record date, payment date, and ex-dividend date for each year. The article also notes that there is no data available for stock splits.
Balchem Corp (BCPC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides a detailed revenue breakdown for Balchem Corp (BCPC), categorizing its income by business segments and geographical regions. It highlights that Product Sales Revenue constitutes the vast majority of its income at 99.82%, with Royalty making up the remainder. Geographically, the United States accounts for 73.22% of the revenue, while foreign countries contribute 26.78%.
Balchem | 3: Initial statement of beneficial ownership of securities- Gilson Erin Leigh
This document is an initial statement of beneficial ownership of securities for Gilson Erin Leigh, pertaining to the company Balchem. These filings are typically required when an individual becomes an insider (e.g., officer, director, or significant shareholder) of a public company.
BCPC Stock Chart | BALCHEM CORP (NASDAQ:BCPC)
This page provides a stock chart for BALCHEM CORP (NASDAQ:BCPC), displaying its daily stock performance. It shows the current stock price, recent changes, and offers various viewing options like daily, weekly, monthly, and different chart types. The page is part of ChartMill.com, which offers various trading tools and market data.
Analysts warn Balchem's high P/E may not be justified by its slower growth, raising concerns that investors are overpaying and could face disappointment if expectations aren't met.
Analysts are concerned that Balchem Corporation's high Price-to-Earnings (P/E) ratio might not be warranted given its slower growth. This suggests that investors could be overpaying for shares of BCPC, potentially leading to disappointment if the company does not meet lofty expectations. The article highlights that earnings alone might not fully reflect the company's story.
Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026
Balchem Corporation announced its participation in the Wells Fargo Industrials Conference on June 10, 2026. Key executives, including Ted Harris (Chairman, President, and CEO), Martin Bengtsson (CFO), and Allison Baurichter (Senior Director Investor Relations), will represent the company. Balchem is a global specialty ingredient manufacturer focusing on health and nutrition markets, with segments in Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026
Balchem Corporation announced its participation in the Wells Fargo Industrials Conference on June 10, 2026. Key executives, including Chairman, President and CEO Ted Harris, CFO Martin Bengtsson, and Senior Director Investor Relations Allison Baurichter, will attend. Balchem is a global specialty ingredient manufacturer focusing on health and nutrition for human and animal markets, as well as specialty chemicals.
Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026
Balchem Corporation announced its participation in the Wells Fargo Industrials Conference on June 10, 2026. Key executives, including Chairman and CEO Ted Harris, CFO Martin Bengtsson, and Senior Director Investor Relations Allison Baurichter, will represent the company. Balchem is a global specialty ingredient manufacturer focusing on health and nutrition markets with three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026
Balchem Corporation announced its participation in the Wells Fargo Industrials Conference on June 10, 2026. Key executives, including Ted Harris, Martin Bengtsson, and Allison Baurichter, will represent the company, which specializes in health and nutrition ingredients across human, animal, and specialty product segments.
Influencer-led education: Inside Balchem’s new consumer awareness strategy
Balchem is implementing a new consumer awareness strategy by partnering with social media influencers to educate consumers about its flagship ingredients. This shift from a purely B2B approach to B2C storytelling aims to establish authority and directly communicate the benefits and quality of dietary supplements. The company is also innovating for the GLP-1 category, re-positioning ingredients for companion products to address potential nutrient gaps for GLP-1 users.
Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026
Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer, announced its participation in the Wells Fargo Industrials Conference on June 10, 2026. Key executives, including Chairman and CEO Ted Harris, CFO Martin Bengtsson, and Senior Director Investor Relations Allison Baurichter, will represent the company. Balchem specializes in ingredients for human nutrition & health, animal nutrition & health, and specialty products markets.
Earnings call transcript: Balchem’s Q1 2026 earnings beat expectations
Balchem Corporation (BCPC) reported strong Q1 2026 financial results, with adjusted EPS of $1.33 and revenue of $270.7 million, both exceeding expectations. Despite a pre-market stock decline, the company achieved its 27th consecutive quarter of year-over-year adjusted EBITDA growth and continues to expand its VitaCholine platform and invest in strategic initiatives. Balchem maintains a positive outlook, anticipating continued growth while addressing inflationary pressures and geopolitical risks.
What Balchem (BCPC)'s Q1 2026 Earnings Growth and Buybacks Mean For Shareholders
Balchem Corporation reported increased sales and net income in Q1 2026, alongside a share repurchase, demonstrating strong profitability and a shareholder-focused capital allocation approach. This combination reinforces the earnings per share impact of its operational performance and aligns with its investment narrative as a specialty nutrition and ingredients provider. However, investors are advised to consider potential risks like margin pressure and differing analyst outlooks despite the positive quarterly results.
